CARL ZEISS MEDITEC ADR 1 Cash Flow Conversion Efficiency

Latest as of September 2025: 0.068x

CARL ZEISS MEDITEC ADR 1 cash flow conversion efficiency. Based on the latest financial reports, CARL ZEISS MEDITEC ADR 1 (AFXA) has a cash flow conversion efficiency ratio of 0.068x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€144.16 Million ≈ $168.54 Million USD) by net assets (€2.13 Billion ≈ $2.49 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of CARL ZEISS MEDITEC ADR 1 (2022–2025)

Cash flow conversion efficiency of CARL ZEISS MEDITEC ADR 1 from 2022 to 2025. This chart illustrates how CARL ZEISS MEDITEC ADR 1's cash flow conversion efficiency has evolved over time, based on yearly financial data. View AFXA stock price and chart for real-time trading data and today's change.

CARL ZEISS MEDITEC ADR 1 Cash Flow Conversion Ratio Explained

CARL ZEISS MEDITEC ADR 1 cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

CARL ZEISS MEDITEC ADR 1 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CARL ZEISS MEDITEC ADR 1 ranked by their cash flow conversion efficiency. Also see AFXA company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
CENTRAL PUERTO ADR/1 AP1 F:C3TA	0.074x
Tiger Brands Ltd JSE:TBS	0.166x
Enterprise Financial Services NASDAQ:EFSC	0.034x
LTC Properties Inc NYSE:LTC	0.049x
Ningbo Zhenyu Technology Co. Ltd. SHE:300953	0.016x
Aurinia Pharmaceuticals Inc NASDAQ:AUPH	0.085x
Stagwell Inc NASDAQ:STGW	0.128x
Hefei Meiya Optoelectronic Technology Inc SHE:002690	0.084x

Annual Cash Flow Conversion Efficiency for CARL ZEISS MEDITEC ADR 1 (2022–2025)

The table below shows the annual cash flow conversion efficiency of CARL ZEISS MEDITEC ADR 1 from 2022 to 2025. Review AFXA free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-09-30	€2.13 Billion ≈ $2.49 Billion	€209.86 Million ≈ $245.35 Million	0.099x	-17.99%
2024-09-30	€2.06 Billion ≈ $2.40 Billion	€247.32 Million ≈ $289.14 Million	0.120x	+4.17%
2023-09-30	€2.17 Billion ≈ $2.54 Billion	€250.86 Million ≈ $293.28 Million	0.115x	+24.53%
2022-09-30	€2.03 Billion ≈ $2.37 Billion	€188.20 Million ≈ $220.02 Million	0.093x	--

About CARL ZEISS MEDITEC ADR 1

F:AFXA Germany Medical Instruments & Supplies

Market Cap

$2.72 Billion

€2.33 Billion EUR

Market Cap Rank

#5695 Global

#899 in Germany

Share Price

€26.60

Change (1 day)

-1.48%

52-Week Range

€22.40 - €65.00

All Time High

€194.84